How a specific gene affects bone health in women
Sexually dimorphic regulation of bone mass by the X-linked histone modifier KDM5C
This study is looking at how a specific gene on the X chromosome affects bone health in women, especially in relation to osteoporosis, to help find better treatments for improving bone strength.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Van Andel Research Institute NIH-funded |
| Lab location | 1 site (Grand Rapids, United States) |
| Project ID | NIH-11170675 on NIH RePORTER |
What this research studies
This research investigates the role of the KDM5C gene, which is linked to the X chromosome, in regulating bone mass specifically in females. The study aims to understand how the loss of this gene influences the function of bone cells called osteoclasts and their interaction with other bone cells. By exploring the genetic and epigenetic mechanisms involved, the researchers hope to uncover new insights into why women are more susceptible to osteoporosis and poorer treatment outcomes. The findings could lead to the development of targeted therapies to improve bone health in women.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are at risk for osteoporosis or have experienced bone loss.
Not a fit: Patients who are not female or those who do not have concerns related to bone health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve bone health and reduce the risk of osteoporosis in women.
How similar studies have performed: Previous research has shown that understanding genetic factors can lead to significant advancements in treatment for conditions like osteoporosis, suggesting that this approach has potential for success.
Where this research is happening
Grand Rapids, United States
- Van Andel Research Institute — Grand Rapids, United States (Active)
Researchers
- Principal investigator: Yang, Tao — Van Andel Research Institute
- Study coordinator: Yang, Tao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.